XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)

第十五届眼部药理学和治疗协会会议（AOPT 2021）

• 批准号: 10308550
• 负责人: Sanjoy K Bhattacharya
• 金额: --
• 依托单位: UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-12-01 至 2023-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10308550
• 关键词: Academia; Age; Anterior; Award; Basic Science; Big Data Methods; Biotechnology; Budgets; Caring; Clinic; Clinical; Clinical Research; Collaborations; Creativeness; Development; Devices; Diagnosis; Discipline; Disease; Drug Delivery Systems; Drug Kinetics; Environment; Ethnic group; Eye; Eye Development; Eye diseases; Feedback; Fellowship; Florida; Fostering; Foundations; Funding; Future; Goals; Grant; Health Professional; Individual; Industry; Institution; International; Intervention; Journals; Knowledge; Leadership; Learning; Logistics; Medicine; Metabolism; Mind; Minority Women; Mission; Natural regeneration; Nature; Occupations; Oral; Participant; Peer Review; Persons; Pharmacologic Substance; Pharmacology; Pharmacy (field); Positioning Attribute; Posterior eyeball segment structure; Private Practice; Publications; Regenerative Medicine; Request for Applications; Research; Research Personnel; Rest; Retina; Safety; Schedule; Scientist; Societies; Stretching; Students; Technology; Therapeutic; Translational Research; Translations; Travel; Underrepresented Minority; Vision; Vision research; Woman; career; editorial; ethnic diversity; insight; interest; lectures; medical schools; meetings; member; neuroprotection; novel; novel therapeutic intervention; novel therapeutics; optic nerve regeneration; posters; pre-clinical; regenerative approach; retinal ganglion cell regeneration; sight restoration; social; symposium; unpublished works; web site

Project Summary The present application requests funds to support travel for young scientists to attend the XV Biennial Meeting of the Association for Ocular Pharmacology and Therapeutics (AOPT) in Miami from March 4th-7th, 2021. This is a conference that brings together scientists who are developing new ways to treat eye diseases. AOPT is a global not-for-profit 501(c)3 organization for scientists and individuals from all disciplines related to ocular pharmacology and its therapeutic applications to eye disease. AOPT has a diverse, multi-national membership composed of preclinical and clinical scientists, students, and healthcare professionals. Members are from academic institutions, pharma and biotech industries, device companies, clinics and private practice. To achieve its mission, the society organizes biennial conferences and provides editorial leadership for the peer- reviewed Journal of Ocular Pharmacology and Therapeutics. The mission of AOPT is threefold (from AOPT website: www.aopt.org): (1) To serve as a global forum and network for the publication, dissemination and exchange of information and knowledge on treatments of eye diseases, from basic and clinical ocular pharmacology and therapeutics to related disciplines such as pharmacokinetics and dynamics, metabolism, translational research, safety, drug delivery, and pharmaceutics; (2)To promote the advancement of research and scientific progress in these fields; (3) To assist researchers and eye-care professionals in furthering their understanding of the treatment of ocular disorders. In line with the AOPT mission, the specific Aims of the R13 application is: (I) To enhance the emerging careers of 20 young scientists (including women and underrepresented minorities) in ocular therapeutics by providing travel awards; (II) To provide a forum for dissemination of the most recent advances in the state of knowledge on novel therapeutic approaches to ocular disorders and disease; (III) To create an environment that will facilitate the exchange of novel ideas among basic and clinician scientists and generate the opportunity for vision scientists of all ethnic groups and social backgrounds to meet and establish research collaborations. The theme of AOPT-2021 is “Restoring vision through Regeneration” and a number of sessions are scheduled which are focused on regenerative medicine related to anterior as well as posterior eye segments.

项目摘要 本申请要求资金支持年轻科学家参加XV双年展会议的旅行 2021年3月4日至7日，迈阿密的眼科和治疗学协会（AOPT） 是一次会议，汇集了正在开发新方法来治疗眼病的科学家。 AOPT是一个 全球非营利性501（c）3组织的科学家和个人组织与所有学科有关 药理学及其在眼病中的治疗应用。 AOPT具有潜水员，跨国会员资格 由临床前和临床科学家，学生和医疗保健专业人员组成。成员来自 学术机构，制药和生物技术行业，设备公司，诊所和私人执业。到 实现其使命，社会组织了两年一次的会议，并为同伴提供编辑领导 综述了眼科药理学和治疗学杂志。 AOPT的任务是三倍（来自AOPT 网站：www.aopt.org）：（1）作为出版，传播和网络的全球论坛和网络 与基本和临床眼的信息交换有关眼病治疗的信息和知识 对相关学科的药理学和治疗，例如药代动力学和动力学，代谢， 翻译研究，安全，药物输送和药物； （2）促进研究的进步 这些领域的科学进步； （3）协助研究人员和眼科专业人员进一步发展 了解眼部疾病的治疗。与AOPT任务一致，R13的具体目的 应用是：（i）增强20位年轻科学家的新兴职业（包括妇女和 通过提供旅行奖，在眼部疗法中代表性不足的少数民族； （ii）提供一个论坛 传播有关新型治疗方法的知识状态的最新进步 眼部疾病和疾病； （iii）创造一个可以促进新思想交流的环境 在基础和临床科学家中，为所有种族的视觉科学家和 社会背景，以满足和建立研究合作。 AOPT-2021的主题是“还原 通过再生的愿景”和许多会议的安排，这些会议侧重于再生 与前眼和后眼段有关的药物。